Riskpilot← Back to searchSign inGet full accessDr Ulrik Lindforss AB
ABActiveOrg 5564434065Västmannagatan 77General medical practice activities · NACE 8621Est. 19920 employees
Revenue 2025
SEK 144K
-49% vs 2024
EBITDA margin
57.5%
-44% vs 2024
Equity ratio
40.3%
Financial strength
Net profit 2025
SEK 84K
-38% vs 2024
| Revenue | SEK 144K | -49% |
| EBITDA | SEK 83K | -44% |
| Net profit | SEK 84K | -38% |
| Total assets | SEK 769K | -11% |
| Equity | SEK 310K | -5% |
| Employees | 0 | — |
Legal name
Dr Ulrik Lindforss AB
Org number
5564434065
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
26 februari 1992
Share capital
SEK 134 600
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultläkartjänster och undervisningsverksamhet såsom föreläsningar, verka som kursledare och traumainstruktör samt äga och förvalta fast och lös egendom, fastigheter och värdepapper samt idka därmed förenlig verksamhet.
Address
Västmannagatan 77
Phone
+4686681292
Email
ulrik.lindforss@ki.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 355 | 172 | 303 | 282 | 144 |
| Staff expenses | — | −7 | −11 | −11 | −6 |
| EBITDA | 252 | 85 | 219 | 148 | 83 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 252 | 85 | 219 | 148 | 83 |
| Net financials | — | — | 3 | 10 | 11 |
| Profit before tax | 270 | 135 | 241 | 172 | 108 |
| Tax | −63 | −32 | −53 | −38 | −25 |
| Net profit | 207 | 103 | 188 | 134 | 84 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 616 | 1 582 | 958 | 868 | 769 |
| Equity | 961 | 1 064 | 372 | 326 | 310 |
| Long-term debt | 69 | 55 | 48 | 104 | 20 |
| Short-term debt | 86 | 13 | 107 | 22 | 39 |
| Total debt | 155 | 68 | 156 | 127 | 59 |
EBITDA margin
57.5%
This company
15.8%
Market median
+264% vs market
20212025
Equity ratio
40.3%
This company
38.2%
Market median
+5% vs market
20212025
Return on equity
27.0%
This company
18.4%
Market median
+47% vs market
20212025
Net profit margin
58.4%
This company
8.1%
Market median
+621% vs market
20212025
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20212025
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Ulrik Lindforss AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Berit Maria Lindfors | Deputy Board Member | 0 companies |
| Per Ulrik Lindfors | Board of Directors | 0 companies |